Le técovirimat dans le traitement de la variole simienne

Sheliza Halani; Derek Leong; Peter E. Wu

doi:10.1503/cmaj.221210-f

Article Information

vol. 195 no. 5 E213-E214

DOI

https://doi.org/10.1503/cmaj.221210-f

PubMed

36746480

History

Published online February 5, 2023.

© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Author Information

Sheliza Halani, MD,
Derek Leong, RPh BScPhm,
Peter E. Wu, MD MSc

Département de médecine (Halani, Wu), et division de pharmacologie clinique et de toxicologie (Wu), Université de Toronto; Département de pharmacie (Leong), Réseau universitaire de santé, Toronto, Ont.